Sweden · Delayed Price · Currency is SEK CellaVision AB Statistics
Total Valuation
CellaVision AB has a market cap or net worth of SEK 4.29 billion. The enterprise value is 4.17 billion.
| Market Cap | 4.29B |
| Enterprise Value | 4.17B |
Important Dates
The next estimated earnings date is Thursday, November 6, 2025.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | May 7, 2025 |
Share Statistics
CellaVision AB has 23.85 million shares outstanding.
| Current Share Class | 23.85M |
| Shares Outstanding | 23.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.89% |
| Owned by Institutions (%) | 61.48% |
| Float | 19.82M |
Valuation Ratios
The trailing PE ratio is 28.40 and the forward PE ratio is 24.15. CellaVision AB's PEG ratio is 1.55.
| PE Ratio | 28.40 |
| Forward PE | 24.15 |
| PS Ratio | 5.71 |
| PB Ratio | 5.22 |
| P/TBV Ratio | 13.86 |
| P/FCF Ratio | 22.40 |
| P/OCF Ratio | 20.81 |
| PEG Ratio | 1.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.25, with an EV/FCF ratio of 21.75.
| EV / Earnings | 27.57 |
| EV / Sales | 5.55 |
| EV / EBITDA | 18.25 |
| EV / EBIT | 21.14 |
| EV / FCF | 21.75 |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.19 |
| Quick Ratio | 2.28 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.16 |
| Interest Coverage | 30.75 |
Financial Efficiency
Return on equity (ROE) is 19.35% and return on invested capital (ROIC) is 15.05%.
| Return on Equity (ROE) | 19.35% |
| Return on Assets (ROA) | 12.30% |
| Return on Invested Capital (ROIC) | 15.05% |
| Return on Capital Employed (ROCE) | 21.45% |
| Revenue Per Employee | 3.28M |
| Profits Per Employee | 660,179 |
| Employee Count | 219 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, CellaVision AB has paid 39.72 million in taxes.
| Income Tax | 39.72M |
| Effective Tax Rate | 20.81% |
Stock Price Statistics
The stock price has decreased by -25.00% in the last 52 weeks. The beta is 1.36, so CellaVision AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.36 |
| 52-Week Price Change | -25.00% |
| 50-Day Moving Average | 178.64 |
| 200-Day Moving Average | 181.81 |
| Relative Strength Index (RSI) | 47.49 |
| Average Volume (20 Days) | 11,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellaVision AB had revenue of SEK 751.47 million and earned 151.18 million in profits. Earnings per share was 6.34.
| Revenue | 751.47M |
| Gross Profit | 517.24M |
| Operating Income | 197.17M |
| Pretax Income | 190.90M |
| Net Income | 151.18M |
| EBITDA | 216.43M |
| EBIT | 197.17M |
| Earnings Per Share (EPS) | 6.34 |
Balance Sheet
The company has 155.28 million in cash and 30.16 million in debt, giving a net cash position of 125.12 million or 5.25 per share.
| Cash & Cash Equivalents | 155.28M |
| Total Debt | 30.16M |
| Net Cash | 125.12M |
| Net Cash Per Share | 5.25 |
| Equity (Book Value) | 822.94M |
| Book Value Per Share | 34.50 |
| Working Capital | 279.24M |
Cash Flow
In the last 12 months, operating cash flow was 206.35 million and capital expenditures -14.72 million, giving a free cash flow of 191.62 million.
| Operating Cash Flow | 206.35M |
| Capital Expenditures | -14.72M |
| Free Cash Flow | 191.62M |
| FCF Per Share | 8.03 |
Margins
Gross margin is 68.83%, with operating and profit margins of 26.24% and 20.12%.
| Gross Margin | 68.83% |
| Operating Margin | 26.24% |
| Pretax Margin | 25.40% |
| Profit Margin | 20.12% |
| EBITDA Margin | 28.80% |
| EBIT Margin | 26.24% |
| FCF Margin | 25.50% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 1.39%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 1.39% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.44% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.39% |
| Earnings Yield | 3.52% |
| FCF Yield | 4.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |